[go: up one dir, main page]

WO2009054360A1 - 内臓脂肪特異的低減剤 - Google Patents

内臓脂肪特異的低減剤 Download PDF

Info

Publication number
WO2009054360A1
WO2009054360A1 PCT/JP2008/069003 JP2008069003W WO2009054360A1 WO 2009054360 A1 WO2009054360 A1 WO 2009054360A1 JP 2008069003 W JP2008069003 W JP 2008069003W WO 2009054360 A1 WO2009054360 A1 WO 2009054360A1
Authority
WO
WIPO (PCT)
Prior art keywords
agent
visceral fat
specifically reducing
reducing visceral
specifically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/069003
Other languages
English (en)
French (fr)
Inventor
Takeshi Ikeda
Koji Morishita
Hironobu Yoshimatsu
Toshiie Sakata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATIONAL UNIVERSITY Corp OITA UNIVERSITY
Kyowa Hakko Bio Co Ltd
Original Assignee
NATIONAL UNIVERSITY Corp OITA UNIVERSITY
Kyowa Hakko Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATIONAL UNIVERSITY Corp OITA UNIVERSITY, Kyowa Hakko Bio Co Ltd filed Critical NATIONAL UNIVERSITY Corp OITA UNIVERSITY
Priority to JP2009538208A priority Critical patent/JPWO2009054360A1/ja
Publication of WO2009054360A1 publication Critical patent/WO2009054360A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

　ヒト、特に肥満者の内臓脂肪特異的低減剤を提供する。本発明は、ヒスチジンまたはその塩を有効成分として含有する、ヒト、特に肥満者に対する内臓脂肪特異的低減剤を提供する。
PCT/JP2008/069003 2007-10-22 2008-10-21 内臓脂肪特異的低減剤 Ceased WO2009054360A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009538208A JPWO2009054360A1 (ja) 2007-10-22 2008-10-21 内臓脂肪特異的低減剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-274146 2007-10-22
JP2007274146 2007-10-22

Publications (1)

Publication Number Publication Date
WO2009054360A1 true WO2009054360A1 (ja) 2009-04-30

Family

ID=40579465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/069003 Ceased WO2009054360A1 (ja) 2007-10-22 2008-10-21 内臓脂肪特異的低減剤

Country Status (2)

Country Link
JP (1) JPWO2009054360A1 (ja)
WO (1) WO2009054360A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015053337A1 (ja) * 2013-10-09 2015-04-16 味の素株式会社 ヒスチジンを含有する食品およびその用途
WO2018181621A1 (ja) * 2017-03-28 2018-10-04 味の素株式会社 腸内環境改善用飼料組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SAKATA T. ET AL.: "Clinical implications of histamine neurons activation driven by mastication and L-histidine: an efficient therapeutic approach to visceral fat reduction and weight loss", THE JAPANESE JOURNAL OF TASTE AND SMELL RESEARCH, vol. 13, no. 3, pages 271 - 276 *
SAKATA T.: "Naizo Shibo Sakugen o Mezashita Himansho Chiryo no Aratanaru Tenkai", JOURNAL OF JAPAN SOCIETY FOR THE STUDY OF OBESITY, vol. 12, 30 September 2006 (2006-09-30), pages 103 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015053337A1 (ja) * 2013-10-09 2015-04-16 味の素株式会社 ヒスチジンを含有する食品およびその用途
CN105592725A (zh) * 2013-10-09 2016-05-18 味之素株式会社 含有组氨酸的食品及其应用
JPWO2015053337A1 (ja) * 2013-10-09 2017-03-09 味の素株式会社 ヒスチジンを含有する食品およびその用途
EP3066937A4 (en) * 2013-10-09 2017-11-01 Ajinomoto Co., Inc. Foodstuff containing histidine and application therefor
US10390553B2 (en) 2013-10-09 2019-08-27 Ajinomoto Co., Inc. Food containing histidine and use thereof
WO2018181621A1 (ja) * 2017-03-28 2018-10-04 味の素株式会社 腸内環境改善用飼料組成物
WO2018181619A1 (ja) * 2017-03-28 2018-10-04 味の素株式会社 腸内環境改善用食品
EP3603421A4 (en) * 2017-03-28 2021-02-17 Ajinomoto Co., Inc. DIET COMPOSITION TO IMPROVE THE INTRAINTESTINAL ENVIRONMENT
EP3603420A4 (en) * 2017-03-28 2021-04-14 Ajinomoto Co., Inc. FOOD TO IMPROVE THE INTRAINTESTINAL ENVIRONMENT
US11376215B2 (en) 2017-03-28 2022-07-05 Ajinomoto Co., Inc. Feed composition for improving intraintestinal environment
US11426347B2 (en) 2017-03-28 2022-08-30 Ajinomoto Co., Inc. Food for improving intraintestinal environment

Also Published As

Publication number Publication date
JPWO2009054360A1 (ja) 2011-03-03

Similar Documents

Publication Publication Date Title
IL198411A0 (en) Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
EP1895950A4 (en) IN HUMAN IMPLANTABLE TISSUE EXPANDERS
ZA200708692B (en) Nanoparticle/active ingredient conjugate
ZA201104600B (en) Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
ZA200702960B (en) Fungicidal active ingredient combinations containing fluoxastrobin
ZA200709999B (en) Fungicidal active ingredient combination
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
TWI366469B (en) Emulsified skin agent for external use
ZA200901447B (en) Aqueous active ingredient concentrate having an herbicidal effect
EP2129330A4 (en) IN HUMAN IMPLANTABLE TISSUE EXPANDERS
WO2009041663A1 (ja) 皮膚疾患の予防及び／または治療剤
EP2196206B8 (en) Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient
IL177061A0 (en) Antimicrobial tissue products with reduced skin irritation potential
EP1829537A4 (en) PREPARATION FOR REDUCTION OF BODILY GREASE
PL2306816T3 (pl) Zastosowanie miejscowych kompozycji do konserwowania ludzkiego lub zwierzęcego ciała
EP2091480A4 (en) SYSTEM FOR THE TREATMENT OF HEART TISSUE
WO2009103959A3 (en) Histidine and/or histidine derivative for the treatment of inflammatory skin diseases
ZA200804757B (en) Fungicidal active ingredient combination
EP2166015A4 (en) LINCOSAMIDE DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING ACTIVE SUBSTANCE
WO2009054360A1 (ja) 内臓脂肪特異的低減剤
WO2011026577A3 (de) Zubereitungen mit wasserunlöslichen polymeren aminen zur verminderung von körpergeruch
WO2008143280A1 (ja) 鎮静剤
IL178190A0 (en) Medical plaster for application on the skin
PL2119700T3 (pl) Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych
TJ405B (en) Preparation vitagin for treatment of endometritis of cows.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08841404

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009538208

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08841404

Country of ref document: EP

Kind code of ref document: A1